Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial
Authors
Keywords
-
Journal
Familial Cancer
Volume 11, Issue 1, Pages 77-84
Publisher
Springer Nature
Online
2011-11-10
DOI
10.1007/s10689-011-9484-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exemestane for Breast-Cancer Prevention in Postmenopausal Women
- (2011) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bilateral prophylactic mastectomy in women with inherited risk of breast cancer – Prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery
- (2010) Jessica Gahm et al. BREAST
- Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women
- (2010) E. A. Waters et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
- (2010) V. G. Vogel et al. Cancer Prevention Research
- Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
- (2010) Mary E. Ropka et al. JOURNAL OF CLINICAL ONCOLOGY
- Are Mastectomy Rates Really Increasing in the United States?
- (2010) Elizabeth B. Habermann et al. JOURNAL OF CLINICAL ONCOLOGY
- Uptake of breast cancer prevention and screening trials
- (2010) D. G. Evans et al. JOURNAL OF MEDICAL GENETICS
- The Increasing Use of Prophylactic Mastectomy in the Prevention of Breast Cancer
- (2010) Todd M. Tuttle et al. Current Oncology Reports
- Should the use of contralateral prophylactic mastectomy be increasing as it is?
- (2009) William C. Wood BREAST
- Surveillance of prophylactic mastectomy
- (2009) Colleen C. McLaughlin et al. CANCER
- Managing the toxicities of the aromatase inhibitors
- (2009) Joanne E Mortimer CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
- (2009) Monika K. Graeser et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of aromatase inhibitors on bone health in breast cancer patients
- (2009) Jürgen Geisler et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
- (2009) T. R. Rebbeck et al. JNCI-Journal of the National Cancer Institute
- IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole
- (2008) Jack Cuzick Expert Review of Anticancer Therapy
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
- (2008) Kelly A. Metcalfe et al. INTERNATIONAL JOURNAL OF CANCER
- Psychological Reactions, Quality of Life, and Body Image After Bilateral Prophylactic Mastectomy in Women At High Risk for Breast Cancer: A Prospective 1-Year Follow-Up Study
- (2008) Yvonne Brandberg et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started